The cancer metabolic reprogramming and immune response.
Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, Liang J, Tang Y, Su M, Luo X, Yang Y, Shi Y, Wang H, Zhou Y, Liao Q.
Xia L, et al.
Mol Cancer. 2021 Feb 5;20(1):28. doi: 10.1186/s12943-021-01316-8.
Mol Cancer. 2021.
PMID: 33546704
Free PMC article.
Review.